Antagonis 5-HT3 (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antagonis 5-HT3" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

11nih.gov

4^th place

13^th place

9doi.org

2^nd place

4^th place

2oxfordjournals.org

1,389^th place

721^st place

2medscape.com

719^th place

1,112^th place

2web.archive.org

1^st place

1alphamedpress.org

low place

1docguide.com

low place

1mims-online.com

low place

alphamedpress.org

theoncologist.alphamedpress.org

Aapro M (2004). "Granisetron: an update on its clinical use in the management of nausea and vomiting". Oncologist. 9 (6): 673–86. doi:10.1634/theoncologist.9-6-673. PMID 15561811. Free full text

docguide.com

"FDA Approves Aloxi (Palonosetron) For Treatment of Chemotherapy-Related Nausea and Vomiting" (Siaran pers). Doctor's Guide Publishing Limited. July 28, 2003. Diakses tanggal 2007-05-15. "Salinan arsip". Archived from the original on 2007-09-28. Diakses tanggal 2016-11-20. Pemeliharaan CS1: Url tak layak (link)

doi.org

de Wit R, Aapro M, Blower PR (2005). "Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?". Cancer Chemother Pharmacol. 56 (3): 231–8. doi:10.1007/s00280-005-1033-0. PMID 15838653.
Roila F, Fatigoni S (2006). "New antiemetic drugs" (PDF). Ann Oncol. 17 Suppl 2: ii96–100. doi:10.1093/annonc/mdj936. PMID 16608997.
Hagan RM, Butler A, Hill JM, Jordan CC, Ireland SJ, Tyers MB (1987). "Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain". Eur. J. Pharmacol. 138 (2): 303–5. doi:10.1016/0014-2999(87)90450-X. PMID 2442006.
Costall B, Gunning SJ, Naylor RJ, Tyers MB (1987). "The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig". Br. J. Pharmacol. 91 (2): 263–4. doi:10.1111/j.1476-5381.1987.tb10280.x. PMC 1853517 . PMID 2955843.
Aapro M (2004). "Granisetron: an update on its clinical use in the management of nausea and vomiting". Oncologist. 9 (6): 673–86. doi:10.1634/theoncologist.9-6-673. PMID 15561811. Free full text
Sorensen SM, Humphreys TM, Palfreyman MG (1989). "Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons". Eur. J. Pharmacol. 163 (1): 115–8. doi:10.1016/0014-2999(89)90402-0. PMID 2744086.
Rabasseda X (February 2002). "Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting". Drugs Today (Barc). 38 (2): 75–89. doi:10.1358/dot.2002.38.2.820104. PMID 12532186.
Hirata T, Funatsu T, Keto Y, Nakata M, Sasamata M (February 2007). "Pharmacological profile of ramosetron, a novel therapeutic agent for IBS". Inflammopharmacology. 15 (1): 5–9. doi:10.1007/s10787-006-1537-1. PMID 17323187.

dx.doi.org

Herrstedt J, Aapro MS, Roila F, Kataja VV (2005). ""ESMO Minimum Clinical Recommendations for prophylaxis of chey-induced nausea and vomiting (NV)"" (PDF). Ann Oncol 16 Suppl 1: i77–9. PMID 15888767. DOI:10.1093/annonc/mdi805

medscape.com

Lindley C, Blower P (2000). "Oral serotonin type 3-receptor antagonists for prevention of chemotherapy-induced emesis". Am J Health-Syst Pharm. 57 (18): 1685–97. PMID 11006796. Free full text with registration at Medscape
Waknine, Yael (September 4, 2008). "FDA Approvals: Nplate, Aloxi, Vidaza". Medscape. Diarsipkan dari versi asli tanggal December 2, 2008. Diakses tanggal 2008-09-04. Freely available with registration.

mims-online.com

Abridged prescribing information - Nasea (MIMS Philippines)^{[pranala nonaktif permanen]}. Retrieved on June 13, 2008.

nih.gov

ncbi.nlm.nih.gov

de Wit R, Aapro M, Blower PR (2005). "Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?". Cancer Chemother Pharmacol. 56 (3): 231–8. doi:10.1007/s00280-005-1033-0. PMID 15838653.
Herrstedt J, Aapro MS, Roila F, Kataja VV (2005). ""ESMO Minimum Clinical Recommendations for prophylaxis of chey-induced nausea and vomiting (NV)"" (PDF). Ann Oncol 16 Suppl 1: i77–9. PMID 15888767. DOI:10.1093/annonc/mdi805
Lindley C, Blower P (2000). "Oral serotonin type 3-receptor antagonists for prevention of chemotherapy-induced emesis". Am J Health-Syst Pharm. 57 (18): 1685–97. PMID 11006796. Free full text with registration at Medscape
Roila F, Fatigoni S (2006). "New antiemetic drugs" (PDF). Ann Oncol. 17 Suppl 2: ii96–100. doi:10.1093/annonc/mdj936. PMID 16608997.
Hagan RM, Butler A, Hill JM, Jordan CC, Ireland SJ, Tyers MB (1987). "Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain". Eur. J. Pharmacol. 138 (2): 303–5. doi:10.1016/0014-2999(87)90450-X. PMID 2442006.
Costall B, Gunning SJ, Naylor RJ, Tyers MB (1987). "The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig". Br. J. Pharmacol. 91 (2): 263–4. doi:10.1111/j.1476-5381.1987.tb10280.x. PMC 1853517 . PMID 2955843.
Aapro M (2004). "Granisetron: an update on its clinical use in the management of nausea and vomiting". Oncologist. 9 (6): 673–86. doi:10.1634/theoncologist.9-6-673. PMID 15561811. Free full text
Sorensen SM, Humphreys TM, Palfreyman MG (1989). "Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons". Eur. J. Pharmacol. 163 (1): 115–8. doi:10.1016/0014-2999(89)90402-0. PMID 2744086.
De Leon A (2006). "Palonosetron (Aloxi): a second-generation 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting". Proceedings (Baylor University. Medical Center). 19 (4): 413–6. PMC 1618755 . PMID 17106506.
Rabasseda X (February 2002). "Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting". Drugs Today (Barc). 38 (2): 75–89. doi:10.1358/dot.2002.38.2.820104. PMID 12532186.
Hirata T, Funatsu T, Keto Y, Nakata M, Sasamata M (February 2007). "Pharmacological profile of ramosetron, a novel therapeutic agent for IBS". Inflammopharmacology. 15 (1): 5–9. doi:10.1007/s10787-006-1537-1. PMID 17323187.

oxfordjournals.org

annonc.oxfordjournals.org

Herrstedt J, Aapro MS, Roila F, Kataja VV (2005). ""ESMO Minimum Clinical Recommendations for prophylaxis of chey-induced nausea and vomiting (NV)"" (PDF). Ann Oncol 16 Suppl 1: i77–9. PMID 15888767. DOI:10.1093/annonc/mdi805
Roila F, Fatigoni S (2006). "New antiemetic drugs" (PDF). Ann Oncol. 17 Suppl 2: ii96–100. doi:10.1093/annonc/mdj936. PMID 16608997.

web.archive.org

"FDA Approves Aloxi (Palonosetron) For Treatment of Chemotherapy-Related Nausea and Vomiting" (Siaran pers). Doctor's Guide Publishing Limited. July 28, 2003. Diakses tanggal 2007-05-15. "Salinan arsip". Archived from the original on 2007-09-28. Diakses tanggal 2016-11-20. Pemeliharaan CS1: Url tak layak (link)
Waknine, Yael (September 4, 2008). "FDA Approvals: Nplate, Aloxi, Vidaza". Medscape. Diarsipkan dari versi asli tanggal December 2, 2008. Diakses tanggal 2008-09-04. Freely available with registration.